Martin Oft
17Patents
5h-index
16Co-inventors
63Inventor score
Filing activity: Feb 16, 1999 → Jan 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7282204B2 | Uses of IL-23 agonists and antagonists; related reagents | Human Necessities | 46 | Expired |
| US10143726B2 | Methods of using interleukin-10 for treating diseases and disorders | Human Necessities | 17 | Active |
| US6383733B1 | Methods of screening for pharmacologically active compounds for the treatment of tumour diseases | Human Necessities | 17 | Expired |
| US9364517B2 | Method of treatment of lymphoma with pegylated IL-10 | Chemistry; Metallurgy | 5 | Active |
| US8865652B2 | Method of treating solid cancers with pegylated IL-10 | Chemistry; Metallurgy | 5 | Active |
| US9970944B2 | Methods of modulating cytokine activity; related reagents | Emerging Cross-Sectional Technologies | 4 | Active |
| US11491205B2 | Biased IL2 muteins methods and compositions | Human Necessities | 2 | Active |
| US10357545B2 | Methods of using interleukin-10 for treating solid tumors | Chemistry; Metallurgy | 2 | Active |
| US8034341B2 | Methods of inhibiting tumor growth using blocking antibodies to IL-23R | Human Necessities | 1 | Active |
| US9833514B2 | Use of pegylated IL-10 to treat cancer | Chemistry; Metallurgy | 1 | Active |
| US9943568B2 | Methods of using pegylated interleukin-10 for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11814679B2 | Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same | Chemistry; Metallurgy | 0 | Active |
| US11648296B2 | IL-2 orthologs and methods of use | Human Necessities | 0 | Active |
| US10568968B2 | Methods for treatment of cancer with therapeutic combinations comprising PEG-IL-10 | Chemistry; Metallurgy | 0 | Active |
| US11413332B2 | Methods of using interleukin-10 for treating diseases and disorders | Human Necessities | 0 | Active |
| US8822405B2 | Uses of mammalian cytokines and agonists; related reagents | Physics | 0 | Active |
| US10653751B2 | Methods of treating cancer metastasis by using interleukin-10 | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.